Engineered Drug Resistant γδ T Cells Kill Glioblastoma Cell Lines during a Chemotherapy Challenge: A Strategy for Combining Chemo- and Immunotherapy

• Lawrence S. Lamb Jr ,

  * E-mail: Lawrence.Lamb@ccc.uab.edu (LSL); hspence@emory.edu (HTS)

  Affiliations Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, United States of America, Department of Surgery, University of Alabama at Birmingham, Birmingham, Alabama, United States of America

  ⨯
• Joscelyn Bowersock,

  Affiliation Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, United States of America

  ⨯
• Anindya Dasgupta,

  Affiliation Emory University School of Medicine, Department of Pediatrics, Aflac Cancer Center and Blood Disorders Service, Atlanta, Georgia, United States of America

  ⨯
• G. Yancey Gillespie,

  Affiliation Department of Surgery, University of Alabama at Birmingham, Birmingham, Alabama, United States of America

  ⨯
• Yun Su,

  Affiliation Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, United States of America

  ⨯
• Austin Johnson,

  Affiliation Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, United States of America

  ⨯
• H. Trent Spencer

  * E-mail: Lawrence.Lamb@ccc.uab.edu (LSL); hspence@emory.edu (HTS)

  Affiliation Emory University School of Medicine, Department of Pediatrics, Aflac Cancer Center and Blood Disorders Service, Atlanta, Georgia, United States of America

  ⨯